ARTICLE | Company News
MicroDose Therapeutx, Moerae Matrix deal
June 25, 2012 7:00 AM UTC
The companies partnered to use MicroDose's inhaler technology to develop a dry powder formulation of Moerae's MMI-0100. The MAP kinase-activated protein kinase 2 ( MAPKAPK2; MK2) inhibitor is in pr...